Target intelligence / Profile preview

Fucose mutarotase (FUOM)

Target
FUOM
Molecular classification
Enzyme, Epimerase, Isomerase
01

Overview

Fucose mutarotase is a cytosolic enzyme (EC 5.1.3.29) that catalyzes the reversible interconversion between alpha-L-fucose and beta-L-fucose, two anomeric forms of this essential six-deoxyhexose sugar. This activity is critical for the salvage pathway of GDP-L-fucose biosynthesis, a key donor in cellular fucosylation of glycoproteins and glycolipids. Fucosylated structures are crucial for processes such as cell-cell adhesion, cell recognition, and immune response. In humans, the enzyme is encoded by the FUOM gene; mutations or dysregulation may contribute to congenital disorders of glycosylation and other defects in cell adhesion or metabolism. While not yet established as a direct drug target, fucose mutarotase is under consideration for future therapeutic development due to its central metabolic function and potential disease linkage.

Other names
L-fucose mutarotasefucose 1-epimerasetype-2 mutarotaseFUCMC10orf125FucUA2VDF0EC 5.1.3.29
02

Mechanism of action

No clinically established drugs; future small-molecule inhibitors or modulators would alter fucose anomer balance and downstream fucosylation

03

Biological functions

Interconversion of alpha- and beta-L-fucose (anomeric conversion)Regulation of fucose salvage metabolismFacilitation of fucosylation for glycoprotein and glycolipid synthesis (modulation of cell-cell adhesion and recognition)
04

Disease associations

Congenital disorder of glycosylation, type IicIschemic neuropathyPotential implication in other disorders related to abnormal fucosylation and cellular adhesion
05

Safety considerations

Not established as a direct safety or toxicity risk; theoretical concerns may relate to broad disruptions of fucosylation in therapeutic context, affecting essential cellular communication

Beyond the preview

Go deeper on Fucose mutarotase (FUOM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fucose mutarotase (FUOM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call